StockData
Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc. (BOLT) stock

BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/305% above fair value
$5.65−0.15 (-2.59%)

Close on Nov 17, 2026Market cap $10.88MP/E –Yield –

Bolt Biotherapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Bolt Biotherapeutics

Bolt Biotherapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Bolt Biotherapeutics figures

See a number that looks wrong?